The University of Texas System | State of Texas Awards $170,500,000 Supplies Contract to Genetix Biotherapeutics Inc (November 2026)
- Disclosed value
- $170,500,000
- From agendapacket
- Approved
- Nov 14, 2026
- Renews
- Free account
The 30-second brief
U.T. Southwestern approved a $170.5 million agreement with Genetix Biotherapeutics for specialty gene therapy products. The agreement covers treatment products for sickle cell-related diseases and automatically renews annually unless terminated with 30 days' notice.
Genetix Biotherapeutics Inc holds this supplies contract with The University of Texas System | State of Texas.
The renewal date is on record. Get free alerts for pre-RFPs like this one, matched to what you sell.
Get pre-RFPs for work like this before the bid is out.
Get pre-RFP alerts freeFree account · 30-second setup · No credit card
Contract details
- Contract type
- Supplies
- Amount
- $170,500,000
- Document date
- November 14, 2026
- Term
- October 6, 2026 through October 5, 2027; automatic one-year renewal terms
- Renews
- On record
- Source document
- U.T. System Board of Regents Agenda Packet 2026-11-18 (AgendaPacket)
Genetix Biotherapeutics Inc's other public contracts
More The University of Texas System | State of Texas contracts
Questions about this contract
Who was awarded the supplies contract by The University of Texas System | State of Texas?
Genetix Biotherapeutics Inc was awarded this supplies contract by The University of Texas System | State of Texas, as recorded on November 14, 2026. The contract value is $170,500,000.
How much is the Genetix Biotherapeutics Inc contract with The University of Texas System | State of Texas worth?
The Genetix Biotherapeutics Inc contract with The University of Texas System | State of Texas is valued at $170,500,000, covering supplies work.
What type of contract is this?
This is a Supplies contract, documented as a agendapacket record.
Where was this contract approved?
This contract appears in U.T. System Board of Regents Agenda Packet 2026-11-18 (AgendaPacket), dated November 14, 2026 from The University of Texas System | State of Texas. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
Show 2 more questions
What other contracts does Genetix Biotherapeutics Inc hold?
Genetix Biotherapeutics Inc may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
What is The University of Texas System | State of Texas currently buying?
Explore The University of Texas System | State of Texas's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.